Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$535M |
| 2 |
Meta Platforms (Facebook)
META
|
+$388M |
| 3 |
SLB Ltd
SLB
|
+$348M |
| 4 |
Visa
V
|
+$230M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$350M |
| 2 |
Chevron
CVX
|
+$349M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$337M |
| 4 |
Dell
DELL
|
+$332M |
| 5 |
SODA
SodaStream International Ltd
SODA
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 13.21% |
| 3 | Financials | 10.74% |
| 4 | Real Estate | 9.97% |
| 5 | Utilities | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Key Tronic
KTCC
$42.8M
| $105K | ﹤0.01% |
18,500
-18,300
| -50% | -$126K |
|
3227
CervoMed
CRVO
$39.6M
| $103K | ﹤0.01% |
691
+405
| +142% | +$138K |
|
3228
Riley Exploration Permian
REPX
$786M
| $103K | ﹤0.01% |
9,041
+131
| +1% | +$1.65K |
|
|
BVSN
3229
DELISTED
Broadvision Inc Com
BVSN
| $103K | ﹤0.01% |
90,500
+400
| +0.4% | +$675 |
|
|
CCRN
3230
DELISTED
Cross Country Healthcare
CCRN
| $101K | ﹤0.01% |
+13,800
| New | +$116K |
|
3231
Enlivex Ltd
ENLV
$28.4M
| $101K | ﹤0.01% |
1,084
+112
| +12% | +$17.2K |
|
3232
Aldeyra Therapeutics
ALDX
$86.9M
| $100K | ﹤0.01% |
12,000
+700
| +6% | +$7.17K |
|
3233
Traws Pharma
TRAW
$9.14M
| $99K | ﹤0.01% |
126
-23
| -15% | -$39.2K |
|
|
TI
3234
DELISTED
Telecom Italia
TI
| $99K | ﹤0.01% |
17,900
-43,372
| -71% | -$260K |
|
3235
Daxor
DXR
$60.7M
| $98K | ﹤0.01% |
12,000
-21,100
| -64% | -$137K |
|
|
IRD
3236
Opus Genetics
IRD
$309M
| $98K | ﹤0.01% |
+2,190
| New | +$128K |
|
|
CSCI
3237
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $97K | ﹤0.01% |
331
| – | – |
|
|
BDR
3238
DELISTED
Blonder Tongue Laboratories Inc
BDR
| $96K | ﹤0.01% |
86,857
-9,701
| -10% | -$10.6K |
|
3239
Dare Bioscience
DARE
$20.5M
| $95K | ﹤0.01% |
11,129
+1,617
| +17% | +$17K |
|
|
VERO
3240
DELISTED
Venus Concept
VERO
| $92K | ﹤0.01% |
+85
| New | +$327K |
|
3241
Newegg Commerce
NEGG
$397M
| $91K | ﹤0.01% |
500
-1
| -0.2% | -$263 |
|
3242
Xtant Medical Holdings
XTNT
$43.8M
| $90K | ﹤0.01% |
56,048
+5,700
| +11% | +$18.4K |
|
|
TISA
3243
DELISTED
TOP Image Systems Ltd
TISA
| $90K | ﹤0.01% |
180,200
+8,300
| +5% | +$6.23K |
|
3244
Armata Pharmaceuticals
ARMP
$177M
| $89K | ﹤0.01% |
30,890
+15,614
| +102% | +$76.1K |
|
3245
Eterna Therapeutics
ERNA
$5.02M
| $89K | ﹤0.01% |
3
| – | – |
|
3246
Koss Corp
KOSS
$34.7M
| $89K | ﹤0.01% |
46,696
-17,400
| -27% | -$40.1K |
|
|
AACG
3247
ATA Creativity
AACG
$48M
| $88K | ﹤0.01% |
95,500
-227,499
| -70% | -$245K |
|
3248
Cellectar Biosciences
CLRB
$19.8M
| $88K | ﹤0.01% |
190
-5
| -3% | -$3.56K |
|
3249
Veru
VERU
$46M
| $87K | ﹤0.01% |
6,230
-1,380
| -18% | -$19K |
|
|
SMRT
3250
DELISTED
Stein Mart Inc
SMRT
| $84K | ﹤0.01% |
78,858
-180,623
| -70% | -$310K |
|
Similar funds
Jim Simons's Q4 2018 Portfolio in Review
As of Q4 2018, Jim Simons held 3,847 positions worth $91.3B, down 6.1% from $97.3B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons deployed $8.84B of net new capital in Q4 2018, opening 522 new positions and adding to 1,588 existing holdings. Its largest new stake was Apple: 11,041,936 shares worth $435M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Dell, an estimated $332M trimmed.
- Jim Simons's largest Q4 2018 buy was Apple: 11,041,936 shares worth $435M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2018, an estimated $388M increase.
- Jim Simons's biggest Q4 2018 reduction was Dell, cutting an estimated $332M.
- Jim Simons fully exited Danaher in Q4 2018, selling an estimated $350M.
- Jim Simons's ten largest holdings make up 9.1% of its $91.3B portfolio in Q4 2018.
- Jim Simons opened 522 new positions and closed 504 in Q4 2018.
- Jim Simons's portfolio value fell 6.1% quarter-over-quarter to $91.3B.
Based on Renaissance Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.